83
Views
34
CrossRef citations to date
0
Altmetric
Review

Prognostic role of serum C-reactive protein in esophageal cancer: a systematic review and meta-analysis

, , &
Pages 89-94 | Published online: 14 Jan 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Zachary Garrison, Noah Hornick, Jeffrey Cheng & Rajan P. Kulkarni. (2022) Circulating biomarkers of response to immunotherapy and immune-related adverse events. Expert Review of Molecular Diagnostics 22:9, pages 855-865.
Read now
Arno Kornberg, Ulrike Witt, Jennifer Kornberg, Katharina Müller, Helmut Friess & Katharina Thrum. (2016) Postoperative peak serum C-reactive protein is a predictor of outcome following liver transplantation for hepatocellular carcinoma. Biomarkers 21:2, pages 152-159.
Read now

Articles from other publishers (32)

Tsuyoshi Harada, Tetsuya Tsuji, Takumi Yanagisawa, Junya Ueno, Nanako Hijikata, Aiko Ishikawa, Keiichi Hiroshige, Daisuke Kotani, Takashi Kojima & Takeo Fujita. (2023) Skeletal muscle mass recovery after oesophagectomy and neoadjuvant chemotherapy in oesophageal cancer: retrospective cohort study. BMJ Supportive & Palliative Care, pages spcare-2023-004245.
Crossref
Tsuyoshi Harada, Tetsuya Tsuji, Noriatsu Tatematsu, Junya Ueno, Yu Koishihara, Nobuko Konishi, Takumi Yanagisawa, Nanako Hijikata, Aiko Ishikawa & Takeo Fujita. (2023) The Postoperative Recovery Course of Skeletal Muscle Mass in Older Esophageal Cancer Patients. European Journal of Cancer Care 2023, pages 1-9.
Crossref
Yoshinori Fujiwara, Shunji Endo, Masaharu Higashida, Hisako Kubota, Kazuhiko Yoshimatsu & Tomio Ueno. (2022) The prognostic significance of preoperative nutritional/inflammatory markers and clinicopathological features in resectable esophagectomy patients: possibility of nutritional intervention. Esophagus 20:2, pages 234-245.
Crossref
Shu-An Wang, Fuchao Li, Jiayu Zhu, Xiaotian Chen, Wei Ren & Bo Gao. (2023) Multidisciplinary nutritional management improves nutritional and hospitalized outcomes of patients with esophageal cancer undergoing chemoradiotherapy: A randomized control trial. Medicine 102:12, pages e33335.
Crossref
Tsuyoshi Harada, Noriatsu Tatematsu, Junya Ueno, Yu Koishihara, Nobuko Konishi, Takuya Fukushima, Hisashi Fujiwara, Takeo Fujita, Nanako Hijikata, Ayako Wada, Aiko Ishikawa & Tetsuya Tsuji. (2022) Impact of early postoperative factors on changes in skeletal muscle mass after esophagectomy in older patients with esophageal cancer. European Geriatric Medicine 14:1, pages 203-210.
Crossref
Tsuyoshi Harada, Tetsuya Tsuji, Junya Ueno, Yu Koishihara, Nobuko Konishi, Nanako Hijikata, Aiko Ishikawa, Daisuke Kotani, Takashi Kojima, Hisashi Fujiwara & Takeo Fujita. (2022) Prognostic Impact of the Loss of Skeletal Muscle Mass During Neoadjuvant Chemotherapy on Older Patients with Esophageal Cancer. Annals of Surgical Oncology 29:13, pages 8131-8139.
Crossref
Hiroaki Iwamoto, Kouji Izumi, Ryunosuke Nakagawa, Ren Toriumi, Shuhei Aoyama, Taiki Kamijima, Takafumi Shimada, Hiroshi Kano, Tomoyuki Makino, Renato Naito, Suguru Kadomoto, Hiroshi Yaegashi, Shohei Kawaguchi, Takahiro Nohara, Kazuyoshi Shigehara, Yoshifumi Kadono & Atsushi Mizokami. (2022) Serum CCL2 Is a Prognostic Biomarker for Non-Metastatic Castration-Sensitive Prostate Cancer. Biomedicines 10:10, pages 2369.
Crossref
Tsuyoshi Harada, Noriatsu Tatematsu, Junya Ueno, Yu Koishihara, Nobuko Konishi, Nanako Hijikata, Aiko Ishikawa, Tetsuya Tsuji, Hisashi Fujiwara & Takeo Fujita. (2022) Prognostic Impact of Postoperative Loss of Skeletal Muscle Mass in Patients Aged 70 Years or Older with Esophageal Cancer. Annals of Surgical Oncology 29:9, pages 5638-5645.
Crossref
Masahiro Tsujiura, Akira Yamamoto, Hiroki Imaoka, Tadanobu Shimura, Takahito Kitajima, Yuhki Morimoto, Mikio Kawamura, Hiromi Yasuda, Yoshiki Okita, Takeshi Yokoe, Yoshinaga Okugawa, Masaki Ohi & Yuji Toiyama. (2022) Clinical utility of lymphocyte to C-reactive protein ratio in predicting survival and postoperative complication for esophago-gastric junction cancer. Surgical Oncology 44, pages 101842.
Crossref
Yilin Yu, Haishan Wu, Jianjian Qiu, Dongmei Ke, Yahua Wu, Mingqiang Lin, Tianxiu Liu, Qunhao Zheng, Hongying Zheng, Jun Yang, Zhiping Wang, Hui Li, Lingyun Liu, Qiwei Yao, Jiancheng Li, Wenfang Cheng & Xiaohui Chen. (2022) A Nutrition-Related Factor-Based Risk Stratification for Exploring the Clinical Benefits in the Treatment of Patients With Locally Advanced Esophageal Squamous Cell Carcinoma Receiving Definitive Chemoradiotherapy: A Retrospective Cohort Study. Frontiers in Nutrition 9.
Crossref
Jing Hu, Zhe Chen, Jiaming Lv, Zhen Zheng, Yanping Bei, Xue Chen, Lu Zheng, Wenjie Song & Yunbao Xu. (2022) The Application of Nimotuzumab Combined With Definitive Chemoradiotherapy Toward the Treatment of Locally Advanced Cervical Esophageal Carcinoma: A Retrospective Study. Frontiers in Oncology 12.
Crossref
Cliona M. Lorton, Larissa Higgins, Niamh O’Donoghue, Claire Donohoe, Jim O’Connell, David Mockler, John V. Reynolds, Declan Walsh & Joanne Lysaght. (2021) C-Reactive Protein and C-Reactive Protein-Based Scores to Predict Survival in Esophageal and Junctional Adenocarcinoma: Systematic Review and Meta-Analysis. Annals of Surgical Oncology 29:3, pages 1853-1865.
Crossref
Marjolein Winsen, Stephen T. McSorley, Ross McLeod, Andrew MacDonald, Matthew J. Forshaw, Martin Shaw & Kathryn Puxty. (2021) Postoperative C‐reactive protein concentrations to predict infective complications following gastrectomy for cancer. Journal of Surgical Oncology 124:7, pages 1060-1069.
Crossref
Keita Kouzu, Hironori Tsujimoto, Hidekazu Sugasawa, Yusuke Ishibashi, Kazuo Hase, Yoji Kishi & Hideki Ueno. (2020) Modified geriatric nutrition risk index as a prognostic predictor of esophageal cancer. Esophagus 18:2, pages 278-287.
Crossref
Georgios Markozannes, Charalampia Koutsioumpa, Sofia Cividini, Grace Monori, Konstantinos K. Tsilidis, Nikolaos Kretsavos, Evropi Theodoratou, Dipender Gill, John PA Ioannidis & Ioanna Tzoulaki. (2020) Global assessment of C-reactive protein and health-related outcomes: an umbrella review of evidence from observational studies and Mendelian randomization studies. European Journal of Epidemiology 36:1, pages 11-36.
Crossref
Yanglan Chen, Rong Cong, Chengjian Ji & Wenhua Ruan. (2020) The prognostic role of C‐reactive protein in patients with head and neck squamous cell carcinoma: A meta‐analysis. Cancer Medicine 9:24, pages 9541-9553.
Crossref
Peter C. Hart, Ibraheem M. Rajab, May Alebraheem & Lawrence A. Potempa. (2020) C-Reactive Protein and Cancer—Diagnostic and Therapeutic Insights. Frontiers in Immunology 11.
Crossref
Øystein Bruserud, Helene Hersvik Aarstad & Tor Henrik Anderson Tvedt. (2020) Combined C-Reactive Protein and Novel Inflammatory Parameters as a Predictor in Cancer—What Can We Learn from the Hematological Experience?. Cancers 12:7, pages 1966.
Crossref
Wen Fu, Kun Wang, Shan Yan, Xie Wang, Bo Tang, Jiang Chang, Ran Wang & Tao Wu. (2020) Prognostic Significance of the Modified Glasgow Prognostic Score in Patients With Pancreatic Cancer: A Meta-Analysis. Dose-Response 18:3, pages 155932582094206.
Crossref
Eo Jin Kim, Jong Hoon Kim, Ho June Song, Sook Ryun Park, Yong‐Hee Kim, Hyeong Ryul Kim & Sung‐Bae Kim. (2020) Impact of sequential lines of palliative chemotherapy in patients with recurrent/metastatic esophageal squamous cell carcinoma: A retrospective analysis of 107 patients at a single center. Asia-Pacific Journal of Clinical Oncology 16:2.
Crossref
Yuji Shishido, Hiroaki Saito, Shota Shimizu, Yusuke Kono, Yuki Murakami, Kozo Miyatani, Tomoyuki Matsunaga, Manabu Yamamoto, Yoji Fukumoto, Soichiro Honjo & Yoshiyuki Fujiwara. (2019) Prognostic significance of platelet × C-reactive protein multiplier in patients with esophageal squamous cell carcinoma. Surgery Today 50:2, pages 185-192.
Crossref
Yan Wang, Xu Hu, Yu Huang, Wen‐Ying Xu, Yan‐Ming Wu, Peng‐Fei Li & Guo‐Wei Che. (2019) Prognostic value of the C‐reactive protein to albumin ratio in esophageal cancer: A systematic review and meta‐analysis. The Kaohsiung Journal of Medical Sciences 36:1, pages 54-61.
Crossref
Hai-yingjie Lin, Guo-qiang Tan, Yan Liu & Shao-qiang Lin. (2019) The prognostic value of serum amyloid A in solid tumors: a meta-analysis. Cancer Cell International 19:1.
Crossref
Stephanie Johnson‐Obaseki, Lisa Caulley, Martin Corsten, Geoffrey Liu, Jim Dimitroulakos, David Goldstein, Jonathan Irish & Jennifer Rider. (2018) C‐reactive Protein in HPV‐Positive and HPV‐Negative Oropharyngeal Cancer. Otolaryngology–Head and Neck Surgery 160:3, pages 494-501.
Crossref
Atsuto Katano, Wataru Takahashi, Hideomi Yamashita, Kentaro Yamamoto, Mizuo Ando, Masafumi Yoshida, Yuki Saito, Osamu Abe & Keiichi Nakagawa. (2017) The impact of elevated C-reactive protein level on the prognosis for oro-hypopharynx cancer patients treated with radiotherapy. Scientific Reports 7:1.
Crossref
S. Shen, J. L. Araujo, N. K. Altorki, J. R. Sonett, A. Rodriguez, K. Sungur-Stasik, C. F. Spinelli, A. I. Neugut & J. A. Abrams. (2017) Variation by stage in the effects of prediagnosis weight loss on mortality in a prospective cohort of esophageal cancer patients. Diseases of the Esophagus 30:9, pages 1-7.
Crossref
G. Jomrich, M. Paireder, A. Gleiss, I. Kristo, L. Harpain & S. F. Schoppmann. (2017) Comparison of Inflammation-Based Prognostic Scores in a Cohort of Patients with Resectable Esophageal Cancer. Gastroenterology Research and Practice 2017, pages 1-10.
Crossref
Guiqin Song, Kang Liu, Xiaoyan Zhu, Xiaolin Yang, Yuewu Shen, Wan Wang, Guidong Shi, Qing Li, Yi Duan, Yunxia Zhao & Gang Feng. (2016) The low IGFBP-3 level is associated with esophageal cancer patients: a meta-analysis. World Journal of Surgical Oncology 14:1.
Crossref
Sarah Louise Morland, Karen J.B. Martins & Vera C. Mazurak. (2016) n-3 polyunsaturated fatty acid supplementation during cancer chemotherapy. Journal of Nutrition & Intermediary Metabolism 5, pages 107-116.
Crossref
Jing Wang, Min Zhou, Xiaoyue Wang, Jingyan Xu, Bing Chen & Jian Ouyang. (2016) Pretreatment C-reactive protein was an independent prognostic factor for patients with diffuse large B-cell lymphoma treated with RCHOP. Clinica Chimica Acta 459, pages 150-154.
Crossref
L. You, L. Ma, W.J. Zhao, Y.P. Zhao & M.H. Dai. (2016) Emerging role of tumor markers and biochemistry in the preoperative invasive assessment of intraductal papillary mucinous neoplasm of the pancreas. Clinica Chimica Acta 454, pages 89-93.
Crossref
Waliza Ansar & Shyamasree GhoshWaliza Ansar & Shyamasree Ghosh. 2016. Biology of C Reactive Protein in Health and Disease. Biology of C Reactive Protein in Health and Disease 207 216 .